Suppr超能文献

人α干扰素和β干扰素可抑制LAV、HTLV - III和ARV - 2的体外复制,但γ干扰素无此作用。

Human alpha- and beta-interferon but not gamma- suppress the in vitro replication of LAV, HTLV-III, and ARV-2.

作者信息

Yamamoto J K, Barré-Sinoussi F, Bolton V, Pedersen N C, Gardner M B

出版信息

J Interferon Res. 1986 Apr;6(2):143-52. doi: 10.1089/jir.1986.6.143.

Abstract

The effect of human interferons (IFNs) (alpha, beta, and gamma) on the in vitro replication of AIDS viruses (LAV, HTLV-III, and ARV-2) in human peripheral blood lymphocytes was investigated. At the time of peak virus production, IFN-alpha preparations (leukocyte, Namalwa, alpha 1, and alpha 2) at 100 U/ml, suppressed LAV, HTLV-III, and ARV-2 replication as measured by reverse transcriptase (RT) activity by greater than 50%. This suppression was dose dependent and high dosages (500 U/ml) of IFN-alpha resulted in almost complete suppression of RT activities (77-99%). A low dose (100 U/ml) of IFN-beta suppressed all three AIDS viruses by 75%. In contrast, human IFN-gamma at a dose range from 100 U/ml to 500 U/ml had no significant effect on the production of infectious viruses. These results indicate that only IFN-alpha and -beta are effective against LAV, HTLV-III, and ARV-2 replication. A continuous supply of IFN appeared to be essential for the constant suppression of RT activity. In fact, upon termination of single IFN treatment, enhanced virus production resulted.

摘要

研究了人干扰素(IFN)(α、β和γ)对艾滋病病毒(LAV、HTLV - III和ARV - 2)在人外周血淋巴细胞中体外复制的影响。在病毒产生高峰期,100 U/ml的IFN - α制剂(白细胞、Namalwa、α1和α2),通过逆转录酶(RT)活性测定,抑制LAV、HTLV - III和ARV - 2的复制超过50%。这种抑制是剂量依赖性的,高剂量(500 U/ml)的IFN - α导致RT活性几乎完全被抑制(77 - 99%)。低剂量(100 U/ml)的IFN - β抑制所有三种艾滋病病毒达75%。相比之下,剂量范围为100 U/ml至500 U/ml的人IFN - γ对传染性病毒的产生没有显著影响。这些结果表明,只有IFN - α和 - β对LAV、HTLV - III和ARV - 2的复制有效。持续供应IFN似乎是持续抑制RT活性所必需的。事实上,单次IFN治疗终止后,病毒产生增强。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验